Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

M Ventures

M Ventures
VC INVESTOR TYPE
Active STATUS
29 PROFESSIONALS
91 INVESTMENTS
47 PORTFOLIO
14 EXITS
Description

Founded in 2009, M Ventures is the corporate venture arm of the Merck Group and headquarters in Amsterdam, The Netherlands with additional offices in Germany, Israel, and the United States. The firm seeks to invest in early-stage companies operating in the technology and medical sectors.

Investor Status
Actively Seeking New Investments
Year Founded
2009
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Accelerator/Incubator
Venture Capital
Primary Office
  • Gustav Mahlerplein 102
  • Toyo lto Building, 20th Floor
  • 1082 MA Amsterdam
  • Netherlands

M Ventures Investments (91)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Immunitas Therapeutics 21-Nov-2019 Early Stage VC 0000 Biotechnology Startup
0000000 000000 17-Jul-2019 00000 00000 00.000 Drug Discovery Generating Revenue/Not Profitable 00000 00000 00.0
00000 09-Jul-2019 0000 00000 000 Food Products Generating Revenue
00000000 000000000 24-Jun-2019 0000 00000 00.000 Biotechnology Startup
0000 00000 17-Jun-2019 0000 00000 000 Financial Software Generating Revenue
00000000 04-Jun-2019 00000 00000 Biotechnology Generating Revenue 0000 000000000 00.0
000000 03-Jun-2019 0000 00000 000 Application Specific Semiconductors Startup
0000000 30-May-2019 00000 00000 00.00 Decision/Risk Analysis Generating Revenue 000000000 00000000
Feelit Technologies 30-May-2019 Seed Round 000.00 Business/Productivity Software Generating Revenue
Riffyn 29-May-2019 Early Stage VC 000.00 Business/Productivity Software Generating Revenue 0000 00000
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore M Ventures’s full profile, request a free trial.

M Ventures Exits (14)

Company Name Exit Date Exit Type Exit Size Status Buyers
Progyny 25-Oct-2019 IPO 00000 Completed
000000000 000 28-Jun-2018 000 00000 Completed
0000000 0000000000 16-Mar-2018 000000000000000000 00.000 Completed
  • 00000000
000000 26-Jan-2017 000 000.00 Completed
0000000 0000000000 01-Apr-2016 000000000000000000 00000 Completed
  • 0000000-00000 0000
00000 17-Jun-2015 0000000000 00000 Completed
  • 3 buyers
000000000000000 06-May-2015 000000000000000000 000.00 Completed
  • 000000 00000000
000000 00000000000 24-Feb-2015 000000000000000000 00000 Completed
  • 00000 00000
Raze Therapeutics 01-Jan-2015 Out of Business Completed
Galecto 03-Nov-2014 Merger/Acquisition 00000 Completed
To view this investor’s complete exits history, request access »

M Ventures Team (67)

Name Title Deals Funds Boards Office Contact
Info
Javier Rodriguez Chief Financial Officer Darmstadt, Germany
Jasper Bos Ph.D Senior Vice President & Managing Director 00 0 0 Amsterdam, Netherlands
Alexander Hoffmann Principal 0 0 Amsterdam, Netherlands
Cheryl Zimberlin Ph.D Principal 0 0 Amsterdam, Netherlands
Hakan Goker Ph.D Executive Director 00 0 0 Amsterdam, Netherlands

35 Former Team Members

You’re viewing 5 of 67 team members. Get the full list »